Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.84%21.61B | 8.51%43.09B | 9.06%20.42B | -19.57%39.71B | -32.73%18.72B | -13.00%49.38B | 4.22%27.83B | 30.44%56.76B | 34.01%26.7B | 5.71%43.51B |
| Operating income | 5.84%21.61B | 8.51%43.09B | 9.06%20.42B | -19.57%39.71B | -32.73%18.72B | -13.00%49.38B | 4.22%27.83B | 30.44%56.76B | 34.01%26.7B | 5.71%43.51B |
| Cost of sales | -9.80%-17.38B | -7.72%-34.6B | -6.66%-15.83B | 13.19%-32.12B | 24.46%-14.84B | 2.45%-37B | -9.06%-19.64B | -21.26%-37.93B | -20.68%-18.01B | 2.68%-31.28B |
| Operating expenses | -9.80%-17.38B | -7.72%-34.6B | -6.66%-15.83B | 13.19%-32.12B | 24.46%-14.84B | 2.45%-37B | -9.06%-19.64B | -21.26%-37.93B | -20.68%-18.01B | 2.68%-31.28B |
| Gross profit | -7.80%4.23B | 11.86%8.49B | 18.22%4.59B | -38.64%7.59B | -52.59%3.88B | -34.26%12.37B | -5.82%8.18B | 53.94%18.82B | 73.76%8.69B | 35.64%12.23B |
| Selling expenses | -6.83%-695M | -5.37%-1.34B | -7.62%-650.54M | 9.91%-1.27B | 27.28%-604.49M | -4.87%-1.41B | -30.08%-831.23M | -15.20%-1.34B | -28.93%-639.02M | 1.72%-1.17B |
| Administrative expenses | -2.24%-1.11B | 6.03%-2.1B | 9.30%-1.09B | 4.16%-2.24B | 13.42%-1.2B | 2.01%-2.33B | -12.55%-1.38B | -19.60%-2.38B | -18.47%-1.23B | 9.23%-1.99B |
| Profit from asset sales | ---- | -83.57%4.93M | -83.57%4.93M | -73.74%30.01M | -67.51%30.01M | -66.52%114.27M | 87.98%92.36M | 150.89%341.27M | -41.89%49.13M | -4.30%136.02M |
| Revaluation surplus | 445.77%1.01B | -138.58%-76.16M | -1,006.83%-293.45M | 153.34%197.41M | 71.71%-26.51M | -264.90%-370.07M | -125.31%-93.72M | 122.81%224.42M | 136.97%370.35M | -2,184.91%-983.72M |
| -Changes in the fair value of investment property | ---- | 71.50%-32.33M | ---- | 23.13%-113.43M | ---- | -1,125.57%-147.56M | ---- | 364.63%14.39M | ---- | -186.81%-5.44M |
| -Changes in the fair value of other assets | 445.77%1.01B | -114.10%-43.83M | -1,006.83%-293.45M | 239.70%310.84M | 71.71%-26.51M | -205.94%-222.51M | -125.31%-93.72M | 121.47%210.03M | 136.97%370.35M | -2,490.73%-978.29M |
| Impairment and provision | ---- | -58.87%-1.42B | -387.78%-11.14M | 43.24%-896.19M | 99.86%-2.28M | ---1.58B | ---1.58B | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -58.87%-1.42B | -387.78%-11.14M | 43.24%-896.19M | 99.86%-2.28M | ---1.58B | ---1.58B | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -43.62%-155.22M | 39.74%-275.48M | 62.47%-108.08M | 39.21%-457.18M |
| Special items of operating profit | -29.19%67.65M | -51.00%156.27M | -36.26%95.54M | 43.20%318.93M | 15.93%149.89M | 411.39%222.72M | 11.19%129.29M | -173.76%-71.52M | 69.34%116.28M | 203.69%96.97M |
| Operating profit | 32.49%3.51B | -0.58%3.71B | 18.71%2.65B | -46.76%3.74B | -48.95%2.23B | -54.17%7.02B | -39.76%4.37B | 94.82%15.31B | 210.91%7.25B | 57.94%7.86B |
| Financing cost | 26.81%-450.29M | 0.72%-1.12B | -22.30%-615.26M | -122.99%-1.12B | ---503.06M | ---504.27M | ---- | ---- | ---- | ---- |
| Share of profits of associates | 14.73%75.11M | 16.89%105.65M | 44.91%65.47M | -50.25%90.38M | -59.82%45.18M | 2.13%181.65M | 118.81%112.43M | 6,754.21%177.87M | 989.54%51.38M | -105.17%-2.67M |
| Share of profit from joint venture company | 2.13%42.69M | -78.85%18.11M | -0.35%41.8M | 5.09%85.63M | 3.16%41.94M | -2.80%81.48M | -3.02%40.66M | 7.66%83.83M | 5.20%41.93M | -17.04%77.87M |
| Earning before tax | 48.41%3.17B | -2.36%2.72B | 17.93%2.14B | -58.87%2.79B | -59.88%1.81B | -56.49%6.78B | -38.44%4.52B | 96.27%15.58B | 210.37%7.34B | 54.92%7.94B |
| Tax | 23.80%-317.94M | -39.46%-618.66M | -45.33%-417.24M | 82.86%-443.61M | 82.27%-287.1M | 14.36%-2.59B | -15.49%-1.62B | -43.38%-3.02B | -69.86%-1.4B | -55.70%-2.11B |
| After-tax profit from continuing operations | 65.91%2.86B | -10.27%2.1B | 12.77%1.72B | -44.04%2.34B | -47.39%1.53B | -66.64%4.19B | -51.16%2.9B | 115.40%12.55B | 285.65%5.94B | 54.64%5.83B |
| Earning after tax | 65.91%2.86B | -10.27%2.1B | 12.77%1.72B | -44.04%2.34B | -47.39%1.53B | -66.64%4.19B | -51.16%2.9B | 115.40%12.55B | 285.65%5.94B | 54.64%5.83B |
| Minority profit | 27.92%274.43M | 68.25%473M | 56.73%214.54M | -47.29%281.13M | -72.18%136.89M | -69.97%533.33M | -44.06%492.02M | 57.80%1.78B | 82.71%879.52M | 66.85%1.13B |
| Profit attributable to shareholders | 71.32%2.58B | -20.97%1.63B | 8.44%1.51B | -43.56%2.06B | -42.33%1.39B | -66.09%3.66B | -52.40%2.41B | 129.18%10.78B | 377.89%5.06B | 51.98%4.7B |
| Basic earnings per share | 71.25%2.329 | -20.96%1.471 | 8.54%1.36 | -43.55%1.861 | -42.34%1.253 | -66.11%3.297 | -52.48%2.173 | 128.54%9.729 | 374.38%4.573 | 49.37%4.257 |
| Diluted earnings per share | 71.25%2.329 | -20.96%1.471 | 8.54%1.36 | -43.55%1.861 | -42.34%1.253 | -66.09%3.297 | -52.44%2.173 | 128.69%9.724 | 374.45%4.569 | 49.25%4.252 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.